查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1931270

腎臟病和泌尿系統失禁器械市場：按器械類型、最終用戶、材料類型、分銷管道、年齡層和性別分類的全球預測，2026-2032年

Nephrology & Urology Incontinence Device Market by Device Type, End User, Material Type, Distribution Channel, Age Group, Gender - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年腎臟和泌尿系統失禁管理設備市場價值為 9.3528 億美元，預計到 2026 年將成長至 9.9314 億美元，預計到 2032 年將達到 15.1118 億美元，複合年成長率為 7.09%。

關鍵市場統計數據
基準年 2025 9.3528億美元
預計年份：2026年 9.9314億美元
預測年份 2032 1,511,180,000 美元
複合年成長率 (%) 7.09%

引言部分清楚地介紹了正在重塑尿失禁器械策略的臨床因素、患者期望、監管重點和商業性趨勢。

尿失禁治療設備融合了臨床需求、病患尊嚴和產業創新。材料科學、設備人體工學和遠距照護模式的最新進展正在改變臨床醫生、看護者和患者與尿失禁治療方案的互動方式。同時，人們對舒適度和感染預防的日益成長的需求正在加速各類設備的改進。此外，報銷機制、醫院採購慣例以及門診服務的擴展也在重塑設備到達最終用戶的途徑。

材料創新、醫療服務分散化以及監管重點正在推動重大變革，重新定義產品開發和採購慣例。

尿失禁醫療設備領域正經歷著變革性的轉變，涵蓋技術創新、照護模式和基於價值的採購。技術正從傳統材料轉向無乳膠材料、矽膠和改良的PVC配方，從而提高生物相容性並減少過敏反應。除了材料方面的進步，設計上的改進也在不斷推進，優先考慮引流控制、造口界面安全性和間歇性導尿的便利性，所有這些都有助於提高治療依從性並降低併發症率。

關稅的累積如何迫使製造商和採購負責人重新設計其供應鏈、籌資策略和定價框架

近期及預期中的關稅變化為醫療設備相關人員的供應鏈規劃和採購決策帶來了新的變數。關稅政策的調整增加了全球採購的複雜性，迫使製造商重新評估零件來源、組裝地點和物流策略，以確保產品供應和臨床應用的連續性。為此，許多企業優先考慮供應商多角化和在地化生產，以降低跨境貿易波動帶來的風險。

基於細分市場的洞察將醫療設備類型、最終用戶需求、材料選擇、通路和人口統計因素與策略性產品和商業性決策聯繫起來。

詳細的細分分析揭示了產品設計、分銷策略和臨床合作的明確意義。依設備類型分類的設備，例如腿袋、導尿管和尿造造口，各自展現出不同的需求促進因素。對於腿袋而言，封閉式和可引流式設計的選擇至關重要，需要在防漏和引流便利性之間取得平衡。導尿管分為留置式和間歇式，其中留置式導尿管（例如 Foley 導尿管和恥骨上導尿管）面臨不同的感染風險。同時，間歇式導尿管根據表面處理方式進行區分，例如親水性、預潤滑和無塗層，這會影響使用者的偏好和訓練需求。此外，尿造造口分為一體式和分離式，這會影響皮膚接觸面的管理和更換頻率。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢將影響監管重點、採​​購行為和在地化策略。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢，各自不同的臨床實務規範、報銷體系和製造地，正在影響市場參與企業的策略選擇。在美洲，對門診醫療基礎設施的集中投資，加上成熟的公立和私立支付體系，催生了對兼具臨床證據、營運效率和供應可靠性的醫療設備的需求。醫療系統對感染預防通訊協定的重視以及與現有臨床工作流程的整合，正在影響採購標準。

關鍵的競爭和企業趨勢表明，產品創新、臨床夥伴關係和分銷管道的完善正在重塑市場定位和市場進入能力。

失禁護理產品領域的競爭格局由擁有廣泛產品線、臨床證據累積和完善分銷管道的公司所主導。主要企業透過漸進式產品創新實現差異化，例如改進導尿管塗層、增強儲尿袋黏合劑以及簡化應用並減少皮膚併發症的模組化系統。除了產品研發之外，與臨床網路和居家醫療提供者建立策略聯盟也有助於拓展市場，並為收集真實世界證據以支持醫保報銷談判創造途徑。

著重於產品安全、供應鏈韌性、通路差異化、證據產生和夥伴關係建立等方面的實用策略建議，旨在實現永續的競爭優勢。

行業領導者應制定切實可行的行動計劃，將市場洞察轉化為永續的優勢。首先，透過選擇優先考慮降低感染風險和提升舒適度的材料和設備設計，並在研發早期階段整合臨床回饋機制，加速產品上市速度。其次，投資於可擴展的培訓和病患教育資源，以支持病患過渡到居家和門診管理。同時，應認知到簡化的說明和數位化輔助能夠減輕看護者的負擔，並提高患者的依從性。

採用透明的混合方法研究策略，結合關鍵相關人員訪談、二手文獻綜述和情境檢驗，確保研究結果具有可靠性和實用性。

本研究採用混合方法，整合並檢驗了臨床、商業和政策領域的相關見解。調查方法包括對臨床醫生、採購經理和護理人員進行定性訪談，以了解真實環境中設備的使用模式、培訓需求和採購決策標準。此外，還透過分析監管指導文件、臨床實踐更新、材料科學文獻和貿易政策公告等二手資料，闡明了營運和合規的促進因素。

總之，我們的綜合研究結果強調了臨床檢驗、以使用者為中心的設計以及供應鏈適應性對於維持臨床應用和普及的重要性。

總而言之，尿失禁治療器材市場正受到多種因素的共同影響而發生重塑：材料創新提升了安全性和舒適度；門診和居家醫療模式的轉變；以及貿易和監​​管壓力對供應鍊和籌資策略的影響。兼具臨床性能和以用戶為中心的設計，並擁有明確的安全性和易用性證據支持的器械，將更容易被醫療專業人員和看護者接受。同時，積極應對供應鏈韌性和關稅風險的企業，將有助於醫療服務提供者和患者獲得穩定的產品供應和價格。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 腎臟病及泌尿系統失禁器械市場（依器械類型分類）

  • 腿袋
  • 尿道管理導管
    • 留置導管
    • 間歇性導尿管
  • 尿造口袋

9. 腎臟病及泌尿系統失禁器械市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 居家醫療
  • 醫院
  • 護理機構

第10章 腎臟病及泌尿系統失禁器械市場（依材料類型分類）

  • 不含乳膠
  • PVC
  • 矽酮

第11章 腎臟病及泌尿系統失禁器械市場（依分銷管道分類）

  • 線上
  • 離線

第12章 按年齡層別分類的腎臟病和泌尿系統失禁器械市場

  • 成人版
  • 老年人
  • 兒童

13. 腎臟病及泌尿系統失禁器械市場（依性別分類）

  • 女士
  • 男性

14. 腎臟病及泌尿系統失禁器械市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 腎臟病及泌尿系統失禁器械市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國腎臟病及泌尿系統失禁器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國腎臟病及泌尿系統失禁器械市場

第18章 中國腎臟泌尿系統失禁器械市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health
  • Coloplast A/S
  • ConvaTec Group plc
  • Cook Group Incorporated
  • Essity AB
  • Fresenius Medical Care AG & Co. KGaA
  • Hollister Incorporated
  • Karl Storz GmbH & Co. KG
  • Kimberly-Clark Corporation
  • Medtronic plc
  • Nikkiso Co., Ltd
  • Olympus Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-7B550E008DFA

The Nephrology & Urology Incontinence Device Market was valued at USD 935.28 million in 2025 and is projected to grow to USD 993.14 million in 2026, with a CAGR of 7.09%, reaching USD 1,511.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 935.28 million
Estimated Year [2026] USD 993.14 million
Forecast Year [2032] USD 1,511.18 million
CAGR (%) 7.09%

An incisive introduction that frames the clinical drivers, patient expectations, regulatory focus, and commercial dynamics reshaping urinary incontinence device strategy

Urinary incontinence devices sit at the intersection of clinical need, patient dignity, and industrial innovation. Recent advances in materials science, device ergonomics, and remote care models have altered how clinicians, caregivers, and patients interact with continence solutions, while rising expectations for comfort and infection prevention have accelerated product refinement across multiple device classes. At the same time, reimbursement frameworks, hospital procurement practices, and ambulatory care expansion are reshaping channels through which devices reach end users.

Transitioning care from acute inpatient settings toward home and outpatient environments has elevated the importance of usability, contamination control, and discreet form factors. Patients and caregivers now expect devices that enhance quality of life without adding clinical complexity, and manufacturers are responding with packaging, instructional design, and digital support tools that reduce training burden. Against this backdrop, regulatory scrutiny of infection rates and device materials has intensified, requiring manufacturers to integrate clinical evidence generation and post-market surveillance into product lifecycles.

Consequently, strategic planning for organizations active in continence care must balance clinical validation, user-centric design, and flexible go-to-market approaches. This introduction outlines core drivers and structural shifts that underpin subsequent sections, setting the stage for deeper analysis of segmentation, regional dynamics, tariff impacts, and pragmatic recommendations for leadership teams.

Critical transformative shifts driven by material innovation, decentralization of care, and regulatory emphasis that are redefining device development and procurement practices

The landscape for urinary incontinence devices is experiencing transformative shifts that span technological innovation, care delivery models, and value-based procurement. On the technology front, the migration away from traditional materials toward latex-free, silicone, and improved PVC formulations is improving biocompatibility and reducing allergic reactions. Material evolution is accompanied by incremental design improvements that prioritize drainage control, ostomy interface security, and ease of intermittent catheterization, which together enhance adherence and reduce complication rates.

Concurrently, clinical practice is decentralizing: more procedures and device management occur in ambulatory surgical centers, outpatient clinics, and home care environments. This movement compels manufacturers to emphasize portability, simplified application procedures, and training resources for non-clinical caregivers. Furthermore, the proliferation of e-commerce and third-party digital platforms is changing procurement behavior, allowing clinicians and patients to compare options and access specialized products outside traditional hospital channels.

Regulatory and payer landscapes are also contributing to the shift. Greater emphasis on infection prevention, device traceability, and reimbursement alignment has increased the importance of clinical evidence and cost-of-care narratives. As a result, companies that can demonstrate measurable outcomes, streamlined supply chains, and post-market support will be better positioned to capitalize on the shift toward patient-centric, outpatient-focused continence care.

How cumulative tariff changes and evolving trade policies are prompting manufacturers and procurers to redesign supply chains, sourcing strategies, and pricing frameworks

Recent and anticipated tariff adjustments have introduced a new variable into supply chain planning and sourcing decisions for medical device stakeholders. Tariff policy changes increase the complexity of global procurement, compelling manufacturers to re-evaluate component sourcing, assembly locations, and logistics strategies to preserve product accessibility and clinical continuity. In response, many organizations are prioritizing supplier diversification and localized manufacturing to mitigate exposure to cross-border trade volatility.

These adjustments also reinforce the need for supply chain transparency and scenario planning. Procurement teams are placing greater emphasis on total landed cost analysis, which incorporates tariff differentials alongside freight, warehousing, and distribution expenses. Such a holistic approach has prompted the reassessment of contract terms, inventory buffers, and lead-time hedging, particularly for components that are sourced from regions where tariff exposure has increased.

Moreover, device makers are accelerating conversations with distribution partners and large health systems about cost-sharing mechanisms, price indexing clauses, and contractual flexibility to accommodate policy shifts. The cumulative effect is a more resilient procurement posture across the ecosystem, where manufacturers, distributors, and providers collaborate to stabilize supply and maintain patient access while navigating the evolving trade environment.

Segmentation-driven insights that connect device typologies, end-user requirements, material choices, distribution pathways, and demographic considerations to strategic product and commercial decisions

A nuanced segmentation analysis reveals clear implications for product design, channel strategy, and clinical engagement. Devices classified by device type-covering leg bags, urinary control catheters, and urostomy pouches-display divergent demand drivers: leg bags require attention to closed versus drainable designs that balance leakage prevention with ease of emptying, urinary control catheters span indwelling and intermittent modalities where indwelling options such as Foley and suprapubic catheters face different infection risk profiles, and intermittent catheters are differentiated by hydrophilic, pre-lubricated, and uncoated finishes that influence user preference and training needs, while urostomy pouches split into one-piece and two-piece assemblies that affect skin interface management and replacement cadence.

End-user segmentation-encompassing ambulatory surgical centers, clinics, home care settings, hospitals, and nursing homes-shapes product specifications and support services; hospital procurement often values institutional sterility and bulk logistics, whereas home care and ambulatory settings prioritize compact packaging, patient education, and remote support. Material type segmentation between latex-free, PVC, and silicone informs allergy mitigation strategies and regulatory positioning, with clinicians increasingly favoring materials that reduce sensitization risk and support infection-control protocols.

Distribution channels, including direct sales, e-commerce, hospital pharmacy, and retail pharmacy, demand tailored commercial approaches: digital channels such as brand websites and third-party platforms, where third-party marketplaces and specialty retail sites play distinct roles, require transparent product information and patient-facing education to drive uptake. Age group and gender segmentation-spanning adult, geriatric, pediatric cohorts and female and male populations-further influence ergonomic design, catheter sizing, and messaging that resonates with caregivers and patients, necessitating targeted clinical evidence and communication strategies to support adoption across diverse user groups.

Region-specific dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine regulatory priorities, procurement behavior, and localization strategies

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific present distinct combinations of clinical practice norms, reimbursement systems, and manufacturing footprints that influence strategic choices for market participants. In the Americas, concentrated investment in outpatient infrastructure, coupled with mature private and public payer systems, creates demand for devices that combine clinical evidence with operational efficiency and supply reliability. Health systems emphasize infection prevention protocols and integration with existing clinical workflows, shaping procurement criteria.

Across Europe, Middle East & Africa, regulatory harmonization in some European markets is counterbalanced by diverse payer structures throughout the broader region, which compels companies to adopt adaptable commercial models and localized clinical value propositions. Here, compliance with regional standards and robust post-market surveillance are vital for market access and long-term adoption. In the Asia-Pacific region, rapid capacity expansion in ambulatory and home care services, alongside growing domestic manufacturing capabilities, is encouraging product innovation focused on affordability, ease of use, and supply chain localization. These regional contrasts necessitate differentiated market entry strategies, partnerships with local distributors and clinical champions, and modular product offerings that can be tailored to regional clinical practices and purchasing behaviors.

Key competitive and corporate trends illustrating how product innovation, clinical partnerships, and channel sophistication are reshaping market positioning and go-to-market capabilities

Competitive dynamics in the continence device arena are shaped by firms that combine product breadth, clinical evidence generation, and channel sophistication. Leading companies are differentiating through incremental product innovation, including improved catheter coatings, enhanced pouch adhesives, and modular systems that simplify application and reduce skin complications. In addition to product development, strategic partnerships with clinical networks and home healthcare providers enhance market penetration and create pathways for real-world evidence collection that supports reimbursement conversations.

Manufacturers that invest in lifecycle support-training modules for caregivers, digital resources for patients, and comprehensive post-market surveillance-tend to achieve higher clinician trust and institutional adoption. At the same time, nimble new entrants are leveraging e-commerce-first strategies and patient-centric branding to capture direct-to-consumer demand, particularly in home care segments. Distributors and specialized suppliers are responding by expanding value-added services such as managed inventory, clinical education programs, and integrated logistics solutions that reduce the administrative burden on hospitals and care providers.

Taken together, the competitive landscape rewards organizations that marry clinical credibility with operational excellence, offering robust evidence of safety and usability while ensuring dependable supply and scalable commercial support. Strategic M&A and collaboration between established players and innovative startups are likely to continue shaping capability sets across the sector.

Actionable strategic recommendations focused on product safety, supply chain resilience, channel differentiation, evidence generation, and partnership development for sustained competitive advantage

Industry leaders should pursue a set of concrete actions to convert market insight into sustainable advantage. First, prioritize material and device design choices that reduce infection risk and enhance comfort, integrating clinical feedback loops early in development to shorten time-to-adoption. Second, invest in scalable training and patient education resources that support transitions to home and outpatient management, recognizing that simplified instructions and digital support reduce caregiver burden and improve adherence.

Third, strengthen supply chain resilience by diversifying suppliers, exploring regional manufacturing hubs, and embedding tariff scenario planning into procurement practices to avoid disruption. Fourth, develop differentiated channel strategies: align direct sales with institutional customers who value clinical support while building a robust digital presence to reach home-care consumers and specialty retail sites. Fifth, build rigorous evidence-generation programs that capture real-world outcomes and device performance across diverse end users and age cohorts, enabling stronger reimbursement narratives and clinician advocacy.

Finally, cultivate strategic partnerships with clinical societies, home healthcare organizations, and distribution specialists to amplify reach and credibility. By combining product excellence, operational resilience, and clear value communication, industry players can accelerate adoption while responding nimbly to regulatory and commercial shifts.

A transparent mixed-method research approach combining primary stakeholder interviews, secondary literature synthesis, and scenario validation to ensure robust and actionable insights

This research synthesis used a mixed-method approach to compile and validate insights across clinical, commercial, and policy domains. The methodology integrated primary qualitative interviews with clinicians, procurement leads, and care providers to capture real-world device usage patterns, training needs, and purchasing considerations. These interviews were complemented by secondary research that examined regulatory guidance documents, clinical practice updates, material science literature, and trade policy notices to contextualize operational and compliance drivers.

Triangulation of findings was achieved by cross-referencing supplier disclosures, device labeling, and peer-reviewed clinical literature to verify performance claims and safety considerations. Additional validation steps included scenario analysis for supply chain and tariff impacts, and consultations with distribution partners to assess channel dynamics and logistical constraints. Where appropriate, patient advocacy perspectives and caregiver feedback were incorporated to ensure the research reflects usability and quality-of-life considerations.

The methodology prioritized transparency, reproducibility, and stakeholder validation to ensure actionable outputs that can inform product development, commercial strategy, and procurement planning without relying on proprietary market sizing assumptions.

A conclusive synthesis emphasizing the necessity of clinical validation, user-focused design, and supply chain adaptability to sustain adoption and access across care settings

In summary, the urinary incontinence device landscape is being reshaped by converging forces: material innovation that enhances safety and comfort, care delivery shifts toward outpatient and home settings, and evolving trade and regulatory pressures that influence supply chain and procurement strategies. Devices that align clinical performance with user-centered design and that are supported by clear evidence of safety and usability will find stronger acceptance among clinicians and caregivers. At the same time, companies that proactively address supply chain resilience and tariff exposure will preserve access and pricing stability for providers and patients.

Strategically, organizations should adopt a bifurcated approach that balances institutional engagement through direct clinical support and integrated logistics while simultaneously building digital channels and patient-facing services for home care adoption. This dual focus helps capture demand across settings without sacrificing quality or compliance. Ultimately, the path forward favors manufacturers and distributors that can demonstrate measurable improvements to care pathways, reduce administrative friction for providers, and maintain flexible operations capable of responding to regulatory and market shifts.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nephrology & Urology Incontinence Device Market, by Device Type

  • 8.1. Leg Bags
  • 8.2. Urinary Control Catheters
    • 8.2.1. Indwelling Catheters
    • 8.2.2. Intermittent Catheters
  • 8.3. Urostomy Pouches

9. Nephrology & Urology Incontinence Device Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Clinics
  • 9.3. Home Care
  • 9.4. Hospitals
  • 9.5. Nursing Homes

10. Nephrology & Urology Incontinence Device Market, by Material Type

  • 10.1. Latex-Free
  • 10.2. PVC
  • 10.3. Silicone

11. Nephrology & Urology Incontinence Device Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline

12. Nephrology & Urology Incontinence Device Market, by Age Group

  • 12.1. Adult
  • 12.2. Geriatric
  • 12.3. Pediatric

13. Nephrology & Urology Incontinence Device Market, by Gender

  • 13.1. Female
  • 13.2. Male

14. Nephrology & Urology Incontinence Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Nephrology & Urology Incontinence Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Nephrology & Urology Incontinence Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Nephrology & Urology Incontinence Device Market

18. China Nephrology & Urology Incontinence Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Asahi Kasei Corporation
  • 19.6. B. Braun SE
  • 19.7. Baxter International Inc.
  • 19.8. Becton, Dickinson and Company
  • 19.9. Boston Scientific Corporation
  • 19.10. Cardinal Health
  • 19.11. Coloplast A/S
  • 19.12. ConvaTec Group plc
  • 19.13. Cook Group Incorporated
  • 19.14. Essity AB
  • 19.15. Fresenius Medical Care AG & Co. KGaA
  • 19.16. Hollister Incorporated
  • 19.17. Karl Storz GmbH & Co. KG
  • 19.18. Kimberly-Clark Corporation
  • 19.19. Medtronic plc
  • 19.20. Nikkiso Co., Ltd
  • 19.21. Olympus Corporation
  • 19.22. Stryker Corporation
  • 19.23. Teleflex Incorporated
  • 19.24. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LEG BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LEG BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LEG BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INDWELLING CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INDWELLING CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INDWELLING CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY UROSTOMY POUCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY UROSTOMY POUCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY UROSTOMY POUCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY NURSING HOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LATEX-FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LATEX-FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LATEX-FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 146. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 170. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 178. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)